- Home
- TXG vs BKV Comparison
TXG vs BKV Comparison
Compare TXG & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- BKV
- Stock Information
- Founded
- TXG 2012
- BKV 2015
- Country
- TXG United States
- BKV United States
- Employees
- TXG N/A
- BKV N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- BKV Oil & Gas Production
- Sector
- TXG Industrials
- BKV Energy
- Exchange
- TXG Nasdaq
- BKV Nasdaq
- Market Cap
- TXG 1.3B
- BKV 1.4B
- IPO Year
- TXG 2019
- BKV 2024
- Fundamental
- Price
- TXG $13.01
- BKV $23.00
- Analyst Decision
- TXG Buy
- BKV Strong Buy
- Analyst Count
- TXG 14
- BKV 9
- Target Price
- TXG $14.96
- BKV $28.00
- AVG Volume (30 Days)
- TXG 4.6M
- BKV 434.2K
- Earning Date
- TXG 08-07-2025
- BKV 08-15-2025
- Dividend Yield
- TXG N/A
- BKV N/A
- EPS Growth
- TXG N/A
- BKV N/A
- EPS
- TXG N/A
- BKV N/A
- Revenue
- TXG $624,662,000.00
- BKV $689,573,000.00
- Revenue This Year
- TXG N/A
- BKV $30.65
- Revenue Next Year
- TXG $6.06
- BKV $33.01
- P/E Ratio
- TXG N/A
- BKV N/A
- Revenue Growth
- TXG N/A
- BKV 2.01
- 52 Week Low
- TXG $6.78
- BKV $15.00
- 52 Week High
- TXG $24.76
- BKV $26.78
- Technical
- Relative Strength Index (RSI)
- TXG 77.06
- BKV N/A
- Support Level
- TXG $11.25
- BKV N/A
- Resistance Level
- TXG $12.11
- BKV N/A
- Average True Range (ATR)
- TXG 0.70
- BKV 0.00
- MACD
- TXG 0.15
- BKV 0.00
- Stochastic Oscillator
- TXG 98.44
- BKV 0.00
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About BKV BKV Corporation Common Stock
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).